Semaglutide has emerged as a promising treatment for insulin resistance. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to release more insulin and suppressing https://ronaldosuk026928.aioblogs.com/88569292/comprehending-semaglutide-a-comprehensive-guide